Global Hyperimmune Globulins Market Growth 2020-2025
According to this study, over the next five years the Hyperimmune Globulins market will register a 7.3%% CAGR in terms of revenue, the global market size will reach $ 2120.1 million by 2025, from $ 1600.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hyperimmune Globulins business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Hyperimmune Globulins, covering the supply chain analysis, impact assessment to the Hyperimmune Globulins market size growth rate in several scenarios, and the measures to be undertaken by Hyperimmune Globulins companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Government Institutions
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Shanghai RAAS
Grifols
Kedrion
CBPO
Biotest
CNBG
Emergent (Cangene)
Hualan Bio
Kamada
Sichuan Yuanda Shuyang
ADMA Biologics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hyperimmune Globulins consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hyperimmune Globulins market by identifying its various subsegments.
Focuses on the key global Hyperimmune Globulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hyperimmune Globulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hyperimmune Globulins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hyperimmune Globulins Consumption 2015-2025
2.1.2 Hyperimmune Globulins Consumption CAGR by Region
2.2 Hyperimmune Globulins Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Other
2.3 Hyperimmune Globulins Consumption by Type
2.3.1 Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
2.3.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2015-2020)
2.3.3 Global Hyperimmune Globulins Sale Price by Type (2015-2020)
2.4 Hyperimmune Globulins Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Globulins Consumption by Application
2.5.1 Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
2.5.2 Global Hyperimmune Globulins Value and Market Share by Type (2015-2020)
2.5.3 Global Hyperimmune Globulins Sale Price by Type (2015-2020)
3 Global Hyperimmune Globulins by Company
3.1 Global Hyperimmune Globulins Sales Market Share by Company
3.1.1 Global Hyperimmune Globulins Sales by Company (2018-2020)
3.1.2 Global Hyperimmune Globulins Sales Market Share by Company (2018-2020)
3.2 Global Hyperimmune Globulins Revenue Market Share by Company
3.2.1 Global Hyperimmune Globulins Revenue by Company (2018-2020)
3.2.2 Global Hyperimmune Globulins Revenue Market Share by Company (2018-2020)
3.3 Global Hyperimmune Globulins Sale Price by Company
3.4 Global Hyperimmune Globulins Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Hyperimmune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hyperimmune Globulins by Regions
4.1 Hyperimmune Globulins by Regions
4.2 Americas Hyperimmune Globulins Consumption Growth
4.3 APAC Hyperimmune Globulins Consumption Growth
4.4 Europe Hyperimmune Globulins Consumption Growth
4.5 Middle East & Africa Hyperimmune Globulins Consumption Growth
5 Americas
5.1 Americas Hyperimmune Globulins Consumption by Countries
5.1.1 Americas Hyperimmune Globulins Consumption by Countries (2015-2020)
5.1.2 Americas Hyperimmune Globulins Value by Countries (2015-2020)
5.2 Americas Hyperimmune Globulins Consumption by Type
5.3 Americas Hyperimmune Globulins Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hyperimmune Globulins Consumption by Regions
6.1.1 APAC Hyperimmune Globulins Consumption by Regions (2015-2020)
6.1.2 APAC Hyperimmune Globulins Value by Regions (2015-2020)
6.2 APAC Hyperimmune Globulins Consumption by Type
6.3 APAC Hyperimmune Globulins Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Hyperimmune Globulins by Countries
7.1.1 Europe Hyperimmune Globulins Consumption by Countries (2015-2020)
7.1.2 Europe Hyperimmune Globulins Value by Countries (2015-2020)
7.2 Europe Hyperimmune Globulins Consumption by Type
7.3 Europe Hyperimmune Globulins Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hyperimmune Globulins by Countries
8.1.1 Middle East & Africa Hyperimmune Globulins Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Hyperimmune Globulins Value by Countries (2015-2020)
8.2 Middle East & Africa Hyperimmune Globulins Consumption by Type
8.3 Middle East & Africa Hyperimmune Globulins Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hyperimmune Globulins Distributors
10.3 Hyperimmune Globulins Customer
11 Global Hyperimmune Globulins Market Forecast
11.1 Global Hyperimmune Globulins Consumption Forecast (2021-2025)
11.2 Global Hyperimmune Globulins Forecast by Regions
11.2.1 Global Hyperimmune Globulins Forecast by Regions (2021-2025)
11.2.2 Global Hyperimmune Globulins Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hyperimmune Globulins Forecast by Type
11.8 Global Hyperimmune Globulins Forecast by Application
12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Information
12.1.2 Hyperimmune Globulins Product Offered
12.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Shanghai RAAS
12.2.1 Company Information
12.2.2 Hyperimmune Globulins Product Offered
12.2.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shanghai RAAS Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Hyperimmune Globulins Product Offered
12.3.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Kedrion
12.4.1 Company Information
12.4.2 Hyperimmune Globulins Product Offered
12.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Kedrion Latest Developments
12.5 CBPO
12.5.1 Company Information
12.5.2 Hyperimmune Globulins Product Offered
12.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CBPO Latest Developments
12.6 Biotest
12.6.1 Company Information
12.6.2 Hyperimmune Globulins Product Offered
12.6.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biotest Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 Hyperimmune Globulins Product Offered
12.7.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Emergent (Cangene)
12.8.1 Company Information
12.8.2 Hyperimmune Globulins Product Offered
12.8.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Emergent (Cangene) Latest Developments
12.9 Hualan Bio
12.9.1 Company Information
12.9.2 Hyperimmune Globulins Product Offered
12.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hualan Bio Latest Developments
12.10 Kamada
12.10.1 Company Information
12.10.2 Hyperimmune Globulins Product Offered
12.10.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Kamada Latest Developments
12.11 Sichuan Yuanda Shuyang
12.11.1 Company Information
12.11.2 Hyperimmune Globulins Product Offered
12.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sichuan Yuanda Shuyang Latest Developments
12.12 ADMA Biologics
12.12.1 Company Information
12.12.2 Hyperimmune Globulins Product Offered
12.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 ADMA Biologics Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Hyperimmune Globulins Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hepatitis B Immunoglobulins
Table 5. Major Players of Rabies Immunoglobulins
Table 6. Major Players of Tetanus Immunoglobulins
Table 7. Major Players of Rho(D) Immunoglobulins
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 11. Global Hyperimmune Globulins Revenue by Type (2015-2020) ($ million)
Table 12. Global Hyperimmune Globulins Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Hyperimmune Globulins Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 16. Global Hyperimmune Globulins Value by Application (2015-2020)
Table 17. Global Hyperimmune Globulins Value Market Share by Application (2015-2020)
Table 18. Global Hyperimmune Globulins Sale Price by Application (2015-2020)
Table 19. Global Hyperimmune Globulins Sales by Company (2017-2019) (K Units)
Table 20. Global Hyperimmune Globulins Sales Market Share by Company (2017-2019)
Table 21. Global Hyperimmune Globulins Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Hyperimmune Globulins Revenue Market Share by Company (2017-2019)
Table 23. Global Hyperimmune Globulins Sale Price by Company (2017-2019)
Table 24. Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Hyperimmune Globulins Products Offered
Table 26. Hyperimmune Globulins Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Hyperimmune Globulins Consumption by Regions 2015-2020 (K Units)
Table 28. Global Hyperimmune Globulins Consumption Market Share by Regions 2015-2020
Table 29. Global Hyperimmune Globulins Value by Regions 2015-2020 ($ Millions)
Table 30. Global Hyperimmune Globulins Value Market Share by Regions 2015-2020
Table 31. Americas Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 33. Americas Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 35. Americas Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 36. Americas Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 37. Americas Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 38. Americas Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 39. APAC Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 41. APAC Hyperimmune Globulins Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Hyperimmune Globulins Value Market Share by Regions (2015-2020)
Table 43. APAC Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 44. APAC Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 45. APAC Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 46. APAC Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 47. Europe Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 49. Europe Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 51. Europe Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 52. Europe Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 53. Europe Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 54. Europe Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 63. Hyperimmune Globulins Distributors List
Table 64. Hyperimmune Globulins Customer List
Table 65. Global Hyperimmune Globulins Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Hyperimmune Globulins Consumption Market Forecast by Regions
Table 67. Global Hyperimmune Globulins Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Hyperimmune Globulins Value Market Share Forecast by Regions
Table 69. Global Hyperimmune Globulins Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Hyperimmune Globulins Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Hyperimmune Globulins Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Hyperimmune Globulins Value Market Share Forecast by Type (2021-2025)
Table 73. Global Hyperimmune Globulins Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Hyperimmune Globulins Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Hyperimmune Globulins Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Hyperimmune Globulins Value Market Share Forecast by Application (2021-2025)
Table 77. CSL Behring Product Offered
Table 78. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. CSL Behring Main Business
Table 80. CSL Behring Latest Developments
Table 81. CSL Behring Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 82. Shanghai RAAS Product Offered
Table 83. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. Shanghai RAAS Main Business
Table 85. Shanghai RAAS Latest Developments
Table 86. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 87. Grifols Product Offered
Table 88. Grifols Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Grifols Main Business
Table 90. Grifols Latest Developments
Table 91. Grifols Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 92. Kedrion Product Offered
Table 93. Kedrion Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Kedrion Main Business
Table 95. Kedrion Latest Developments
Table 96. Kedrion Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 97. CBPO Product Offered
Table 98. CBPO Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. CBPO Main Business
Table 100. CBPO Latest Developments
Table 101. CBPO Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 102. Biotest Product Offered
Table 103. Biotest Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Biotest Main Business
Table 105. Biotest Latest Developments
Table 106. Biotest Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 107. CNBG Product Offered
Table 108. CNBG Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 109. CNBG Main Business
Table 110. CNBG Latest Developments
Table 111. CNBG Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Emergent (Cangene) Product Offered
Table 113. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Emergent (Cangene) Main Business
Table 115. Emergent (Cangene) Latest Developments
Table 116. Emergent (Cangene) Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 117. Hualan Bio Product Offered
Table 118. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. Hualan Bio Main Business
Table 120. Hualan Bio Latest Developments
Table 121. Hualan Bio Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 122. Kamada Product Offered
Table 123. Kamada Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 124. Kamada Main Business
Table 125. Kamada Latest Developments
Table 126. Kamada Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 127. Sichuan Yuanda Shuyang Product Offered
Table 128. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 129. Sichuan Yuanda Shuyang Main Business
Table 130. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Sichuan Yuanda Shuyang Latest Developments
Table 132. ADMA Biologics Product Offered
Table 133. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 134. ADMA Biologics Main Business
Table 135. ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. ADMA Biologics Latest Developments
List of Figures
Figure 1. Picture of Hyperimmune Globulins
Figure 2. Hyperimmune Globulins Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Hyperimmune Globulins Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Hyperimmune Globulins Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hepatitis B Immunoglobulins
Figure 7. Product Picture of Rabies Immunoglobulins
Figure 8. Product Picture of Tetanus Immunoglobulins
Figure 9. Product Picture of Rho(D) Immunoglobulins
Figure 10. Product Picture of Other
Figure 11. Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Figure 12. Global Hyperimmune Globulins Value Market Share by Type (2015-2020)
Figure 13. Hyperimmune Globulins Consumed in Government Institutions
Figure 14. Global Hyperimmune Globulins Market: Government Institutions (2015-2020) (K Units)
Figure 15. Global Hyperimmune Globulins Market: Government Institutions (2015-2020) ($ Millions)
Figure 16. Hyperimmune Globulins Consumed in Private Sector
Figure 17. Global Hyperimmune Globulins Market: Private Sector (2015-2020) (K Units)
Figure 18. Global Hyperimmune Globulins Market: Private Sector (2015-2020) ($ Millions)
Figure 19. Hyperimmune Globulins Consumed in Other
Figure 20. Global Hyperimmune Globulins Market: Other (2015-2020) (K Units)
Figure 21. Global Hyperimmune Globulins Market: Other (2015-2020) ($ Millions)
Figure 22. Global Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Figure 23. Global Hyperimmune Globulins Value Market Share by Application (2015-2020)
Figure 24. Global Hyperimmune Globulins Sales Market Share by Company in 2017
Figure 25. Global Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 26. Global Hyperimmune Globulins Revenue Market Share by Company in 2017
Figure 27. Global Hyperimmune Globulins Revenue Market Share by Company in 2019
Figure 28. Global Hyperimmune Globulins Sale Price by Company in 2019
Figure 29. Global Hyperimmune Globulins Consumption Market Share by Regions 2015-2020
Figure 30. Global Hyperimmune Globulins Value Market Share by Regions 2015-2020
Figure 31. Americas Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 32. Americas Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 33. APAC Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 34. APAC Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 35. Europe Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 36. Europe Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 39. Americas Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 40. Americas Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 41. Americas Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 42. Americas Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 43. United States Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 44. United States Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 50. APAC Hyperimmune Globulins Value Market Share by Regions in 2019
Figure 51. APAC Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 52. APAC Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 53. China Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 54. China Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 61. India Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 62. India Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 66. Europe Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 67. Europe Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 68. Europe Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 69. Germany Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 71. France Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 72. France Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 73. UK Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 74. UK Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 83. Egypt Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 93. Global Hyperimmune Globulins Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Hyperimmune Globulins Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 96. Americas Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 97. APAC Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 98. APAC Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 99. Europe Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 100. Europe Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 103. United States Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 104. United States Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 105. Canada Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 106. Canada Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 107. Mexico Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 108. Mexico Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 109. Brazil Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 110. Brazil Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 111. China Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 112. China Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 113. Japan Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 114. Japan Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 115. Korea Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 116. Korea Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 119. India Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 120. India Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 121. Australia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 122. Australia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 123. Germany Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 124. Germany Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 125. France Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 126. France Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 127. UK Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 128. UK Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 129. Italy Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 130. Italy Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 131. Russia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 132. Russia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 133. Spain Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 134. Spain Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 135. Egypt Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 136. Egypt Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 137. South Africa Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 138. South Africa Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 139. Israel Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 140. Israel Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 141. Turkey Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 142. Turkey Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 145. CSL Behring Hyperimmune Globulins Market Share (2018-2020)
Figure 146. Shanghai RAAS Hyperimmune Globulins Market Share (2018-2020)
Figure 147. Grifols Hyperimmune Globulins Market Share (2018-2020)
Figure 148. Kedrion Hyperimmune Globulins Market Share (2018-2020)
Figure 149. CBPO Hyperimmune Globulins Market Share (2018-2020)
Figure 150. Biotest Hyperimmune Globulins Market Share (2018-2020)
Figure 151. CNBG Hyperimmune Globulins Market Share (2018-2020)
Figure 152. Emergent (Cangene) Hyperimmune Globulins Market Share (2018-2020)
Figure 153. Hualan Bio Hyperimmune Globulins Market Share (2018-2020)
Figure 154. Kamada Hyperimmune Globulins Market Share (2018-2020)
Figure 155. Sichuan Yuanda Shuyang Hyperimmune Globulins Market Share (2018-2020)
Figure 156. ADMA Biologics Hyperimmune Globulins Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets